Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis

被引:0
|
作者
Pitre, Tyler [1 ]
Lupas, Daniel [2 ]
Ebeido, Ibrahim [3 ]
Colak, Alexander [4 ]
Modi, Mihir [2 ]
V. Kachkovski, George [3 ]
Montesi, Sydney B. [5 ]
Khor, Yet H. [6 ,7 ,8 ,9 ]
Kawano-Dourado, Leticia [10 ,11 ,12 ]
Jenkins, Gisli [13 ]
Fisher, Jolene H. [1 ]
Shapera, Shane [1 ]
Rochwerg, Bram [14 ,15 ]
Couban, Rachel [16 ]
Zeraatkar, Dena [14 ,16 ]
机构
[1] Univ Toronto, Dept Med, Div Respirol, Toronto, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[3] McMaster Univ, Fac Hlth Sci, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ British Columbia, Fac Med, Kelowna, BC, Canada
[5] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA USA
[6] Monash Univ, Cent Clin Sch, Resp Res Alfred, Melbourne, Vic, Australia
[7] Austin Hlth, Dept Resp & Sleep Med, Heidelberg, Vic, Australia
[8] Inst Breathing & Sleep, Heidelberg, Vic, Australia
[9] Univ Melbourne, Fac Med, Melbourne, Vic, Australia
[10] Hosp Coracao, Hcor Res Inst, Sao Paulo, Brazil
[11] Univ Sao Paulo, Pulm Div, Sao Paulo, Brazil
[12] Stat Norway, Oslo, Norway
[13] Imperial Coll London, Natl Heart & Lung Inst, Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England
[14] McMaster Univ, Dept Med, Hamilton, ON, Canada
[15] McMaster Univ, Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[16] McMaster Univ, Dept Anesthesiol, Hamilton, ON, Canada
关键词
IPF; Prognostic factors; Acute exacerbations; Meta-analysis; INTERSTITIAL PNEUMONIA; THROMBOMODULIN; EFFICACY; INDEX; BIAS;
D O I
10.1016/j.rmed.2023.107515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) increases mortality risk, but which factors increase mortality is unknown. We aimed to perform a prognostic review of factors associated with mortality in patients with IPF. Study design: and methods: We searched MEDLINE, EMBASE, and CINAHL for studies that reported on the association between any prognostic factor and AE-IPF. We assessed risk of bias using the QUIPS tool. We conduced pairwise meta -analyses using REML heterogeneity estimator, and GRADE approach to assess the certainty of the evidence. Results: We included 35 studies in our analysis. We found that long-term supplemental oxygen at baseline (aHR 2.52 [95 % CI 1.68 to 3.80]; moderate certainty) and a diagnosis of IPF compared to non-IPF ILD (aHR 2.19 [95 % CI 1.22 to 3.92]; moderate certainty) is associated with a higher risk of death in patients with AE-IPF. A diffuse pattern on high resolution computed tomography (HRCT) compared to a non -diffuse pattern (aHR 2.61 [95 % CI 1.32 to 2.90]; moderate certainty) is associated with a higher risk of death in patients with AE-IPF. We found that using corticosteroids prior to hospital admission (aHR 2.19 [95 % CI 1.26 to 3.82]; moderate certainty) and those with increased neutrophils (by % increase) in bronchoalveolar lavage (BAL) during the exacerbation is associated with a higher risk of death (aHR 1.02 [1.01 to 1.04]; moderate certainty). Interpretation: Our results have implications for healthcare providers in making treatment decisions and prognosticating the clinical trajectory of patients, for researchers to design future interventions to improve patient trajectory, and for guideline developers in making decisions about resource allocation.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
    Kamiya, Hiroyuki
    Panlaqui, Ogee Mer
    BMJ OPEN, 2020, 10 (06):
  • [2] Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis
    Kamiya, Hiroyuki
    Panlaqui, Ogee Mer
    BMJ OPEN, 2019, 9 (05):
  • [3] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Zheng, Qiang
    Cox, Ingrid A.
    Campbell, Julie A.
    Xia, Qing
    Otahal, Petr
    de Graaff, Barbara
    Corte, Tamera J.
    Teoh, Alan K. Y.
    Walters, E. Haydn
    Palmer, Andrew J.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [4] Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Qiu, Meihua
    Chen, Yuqing
    Ye, Qiao
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (03): : 1084 - 1092
  • [5] Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Kamiya, Hiroyuki
    Panlaqui, Ogee
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Impact of emphysema on mortality in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Wang, Yanhong
    Zou, Ruyi
    Yao, Yu
    Tang, Cheng
    Luo, Jing
    Lin, Minjie
    EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [7] Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Petnak, Tananchai
    Lertjitbanjong, Ploypin
    Thongprayoon, Charat
    Moua, Teng
    CHEST, 2021, 160 (05) : 1751 - 1763
  • [8] The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Wang, Yan
    Ji, Zile
    Xu, Baichuan
    Li, Suyun
    Xie, Yang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [9] Mortality and Survival in Idiopathic Pulmonary Fibrosis: An Updated Comprehensive Systematic Review and Meta-Analysis
    Zheng, Q.
    Cox, I.
    Campbell, J.
    Xia, Q.
    Otahal, P.
    de Graaff, B.
    Corte, T. J.
    Teoh, A. K.
    Walters, E. H.
    Palmer, A. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Aravena, Carlos
    Labarca, Gonzalo
    Venegas, Carmen
    Arenas, Alex
    Rada, Gabriel
    PLOS ONE, 2015, 10 (08):